Abstract
Mycobacterium ulcerans, the opportunistic pathogen causing Buruli ulcer, is reported to affect rural populations in 36 tropical countries. We report one case of Buruli ulcer in a peri-urban area in Côte d'Ivoire, confirmed by whole genome sequencing which indicated a M. ulcerans genotype previously unreported in Côte d'Ivoire.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-Bacterial Agents / therapeutic use*
-
Azithromycin / therapeutic use
-
Buruli Ulcer / diagnosis*
-
Buruli Ulcer / drug therapy
-
Buruli Ulcer / microbiology
-
Buruli Ulcer / pathology
-
Cities
-
Cote d'Ivoire
-
Genome, Bacterial*
-
Genotype*
-
Humans
-
Male
-
Middle Aged
-
Mycobacterium ulcerans / classification
-
Mycobacterium ulcerans / drug effects
-
Mycobacterium ulcerans / genetics*
-
Mycobacterium ulcerans / pathogenicity
-
Phylogeny
-
Rifampin / therapeutic use
-
Whole Genome Sequencing
Substances
-
Anti-Bacterial Agents
-
Azithromycin
-
Rifampin